| Sara Emily Islam, MD | |
|
2500 N State St, Jackson, MS 39216-4500 | |
| (601) 984-1000 | |
| Not Available |
| Full Name | Sara Emily Islam |
|---|---|
| Gender | Female |
| Speciality | Surgery - Plastic And Reconstructive Surgery |
| Location | 2500 N State St, Jackson, Mississippi |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1285338301 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2086S0122X | Surgery - Plastic And Reconstructive Surgery | T-5041 (Mississippi) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Sara Emily Islam, MD 7 Saras Way, Bethel, CT 06801-2949 Ph: () - | Sara Emily Islam, MD 2500 N State St, Jackson, MS 39216-4500 Ph: (601) 984-1000 |
News Archive
Harbour BioMed, a global clinical stage biopharmaceutical company and Viva Biotech (Shanghai) Ltd., a world-leading structure-based drug discovery platform today announced a strategic partnership under which both parties will collate their respective expertise in drug discovery and development to promote the incubation of innovative biotech startups.
One of the biggest concerns facing Americans and people worldwide today is the absence of clean, sanitary drinking water. Over the past few years people have begun to wake up to the fact that their tap water isn't as clean as they originally thought; the discovery has been made that a large portion of drinking water in the United States is laced with pharmaceuticals and chemicals.
Contrary to existing understanding, long-term follow-up of patients with two types of breast tissue abnormalities suggests that both types of abnormalities have the same potential to progress to breast cancer, according to a study published in Cancer Prevention Research, a journal of the American Association for Cancer Research. Findings from this study could improve clinical management of patients with breast tissue abnormalities.
Long-term use of a macrolide antibiotic may reduce the frequency of exacerbations in patients with moderate to severe chronic obstructive pulmonary disease (COPD) by as much as 35 percent, according to a London-based study.
Impax Laboratories, Inc. today confirms that it has initiated a challenge of patents listed by Shire Development Inc. in connection with INTUNIVTM (guanfacine hydrochloride), 4 mg.
› Verified 2 days ago
Dr. Wayne Shannon Orr Iii, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 2500 N State St, Jackson, MS 39216 Phone: 601-984-5452 Fax: 601-815-3322 | |
Jacob M Folse, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 2500 N State St, Jackson, MS 39216 Phone: 601-984-5153 Fax: 601-984-6962 | |
Robert Eugene Schmieg Jr., MD Surgery Medicare: Not Enrolled in Medicare Practice Location: 2500 N State St, Jackson, MS 39216 Phone: 601-984-1000 Fax: 601-926-4978 | |
Dr. Hal Gregory Fiser, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 1190 N State St, Suite 502, Jackson, MS 39202 Phone: 601-944-1781 Fax: 601-353-0439 | |
Pierre Edouard De Delva, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 2500 N State St, University Of Mississippi Medical Center, Jackson, MS 39216 Phone: 601-984-5170 | |
Dr. John Magruder Sullivan Iii, MD Surgery Medicare: Not Enrolled in Medicare Practice Location: 2500 N State St, Jackson, MS 39216 Phone: 601-984-1000 | |
Colton Lott, Surgery Medicare: Not Enrolled in Medicare Practice Location: 2500 N State St, Jackson, MS 39216 Phone: 601-815-1292 Fax: 601-984-5110 |